The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of neoadjuvant therapy on breast conservation rates in triple-negative and HER2-positive breast cancer: Combined results of CALGB 40603 and 40601 (Alliance).
 
Mehra Golshan
No Relationships to Disclose
 
Constance T. Cirrincione
No Relationships to Disclose
 
Lisa A. Carey
Research Funding - Genentech/Roche; GlaxoSmithKline
 
William M. Sikov
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Abbvie; Celgene
 
Donald A. Berry
Employment - Berry Consultants
Leadership - Berry Consultants
Stock and Other Ownership Interests - Berry Consultants
Consulting or Advisory Role - Berry Consultants
Travel, Accommodations, Expenses - Berry Consultants
 
Harold J. Burstein
No Relationships to Disclose
 
Beth Overmoyer
No Relationships to Disclose
 
Norah Lynn Henry
Research Funding - BioMarin; Celldex; Sanofi
Travel, Accommodations, Expenses - Celldex
 
George Somlo
No Relationships to Disclose
 
Elisa R. Port
No Relationships to Disclose
 
Eric P. Winer
Consulting or Advisory Role - Genentech/Roche; Novartis; Verastem
Research Funding - Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Novartis
 
Clifford A. Hudis
Other Relationship - Breast Cancer Research Foundation
 
David W. Ollila
No Relationships to Disclose